12:00 AM
Apr 17, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Visudyne verteporfin for injection regulatory update

The FDA granted marketing approval for Visudyne photodynamic therapy to treat wet age-related macular degeneration (AMD) in patients with predominantly classic subfoveal...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >